Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Investig Med. 2018 Aug 19;66(8):1088–1095. doi: 10.1136/jim-2018-000807

Figure 1.

Figure 1.

Novel AML Targets and Therapies

Abbreviations: NEDD-8, neural precursor cell expressed, developmentally down-regulated 8-activating enzyme; IDH, isocitrate dehydrogenase; BCL2, B-cell Lymphoma 2; FLT3, fms like tyrosine kinase 3; CAR, chimeric antigen receptor; DART, dual-affinity re-targeting antibody.